Inhibikase Therapeutics Earning Date (IKT)

USA |NASDAQ |USD

IKT Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 15, 2022 Jun 2022 - - $-0.18
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 15, 2022 Jun 2022 - - $1.36M

Inhibikase Therapeutics's next earnings date is Monday, Aug 15, 2022 for the fiscal quarter ending Jun 2022.

IKT Earnings Date & History Chart

IKT Earnings & Revenue Forecast

IKT Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 1 $-0.61 $-0.61 $-0.61

IKT Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-0.56 $-0.67 $-0.67

IKT Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 1 $2.70M $2.70M $2.70M

IKT Earnings Date & Revenue History

IKT Earnings History

|
Show More
Show More

IKT Revenue History

|
Show More
Show More

Inhibikase Therapeutics Next Earnings Date & Report

IKT Next Earnings Date & Report Preview: Jun 2022 (FQ)

IKT's next earnings date is Monday, Aug 15, 2022 for the fiscal quarter ending Jun 30, 2022.

Inhibikase Therapeutics Previous Earnings Dates & Reports

IKT Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Inhibikase Therapeutics's previous earnings date was May 16, 2022 for its fiscal quarter ended Mar 31, 2022.

IKT Previous Earnings Date & Report Recap: Dec 2020 (FY)

Inhibikase Therapeutics's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.

IKT's earnings per share (EPS) was $-0.54.

Revenues were $698.47K, down by -37.79% from previous year's revenue.

The company reported a net income of $-2.85M.

Inhibikase Therapeutics reported a free cash flow of $-1.13M for its fiscal year, compared to $-338.29K a year ago.

The company ended the fiscal year with $42.53 in total debt, a decrease of -99.99% compared to the previous year.